Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3 - Wikidata - wikimedia - TriplyDB

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

http://www.wikidata.org/entity/Q24291630

about

Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2 Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1 FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1 Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis Lymphatic endothelium: morphological, molecular and functional properties Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis Lymphatic vascular response to acute inflammation Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination.Structural determinants of growth factor binding and specificity by VEGF receptor 2 Deciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast Cancer Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in Chinese hamster ovary cells Lymphatic function is required prenatally for lung inflation at birth.T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature Smooth muscle-endothelial cell communication activates Reelin signaling and regulates lymphatic vessel formation Tbx1 regulates Vegfr3 and is required for lymphatic vessel development NFATc1 regulates lymphatic endothelial development Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium Elevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin Tumors Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades.CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development.Specialization of tumour vasculature.Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas Phosphorylation regulates FOXC2-mediated transcription in lymphatic endothelial cells Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors.Tumour vascularization: sprouting angiogenesis and beyond Liprin (beta)1 is highly expressed in lymphatic vasculature and is important for lymphatic vessel integrity.Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha.VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy Lymphangiogenesis and lymphatic metastasis in breast cancer.The lymphatic system in health and disease.Endothelial cell Bcl-2 and lymph node metastasis in patients with oral squamous cell carcinoma.Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.

P2860

877b8b0ac45b3a17a9f559c2ecc7f078bcd2097f 90051488a07761554535a32ca8ccde930016c049 bf143a5a5d582b92eb388305d6ec7a1a07eaee5a

P248

Q24297590-A01CE045-69BC-4F85-AC81-57BEBD92130F Q24300714-5DA8DA81-2568-46D2-8BFF-6E90C4BDE10C Q24303560-FBE68F94-C1B7-4653-90A0-97D9D4CC7B9B Q24305315-5B3086CD-E643-445A-9A72-B7764D1A979A Q24318473-BBD6B81A-FF6F-44D2-9B9D-B40D34031DD6 Q24538981-73F91C86-5543-40FC-B6E0-A28261701C6B Q24641842-D37EFB98-EC52-499E-90D0-C1EB5DCF78C4 Q24669710-C19884B7-0049-46EE-92A0-4BDF391DB138 Q24672687-19900FA0-B333-4D11-90A2-C9B2873314FA Q26745683-54FFBE76-DA07-43A2-9298-DB1054A66EC7 Q26796921-337C931D-35E4-4E6C-8BF2-6035F3CB1602 Q27304915-7DB1D95B-4AF7-40A4-A2A4-E9FD6C6486DE Q27333172-BD596E97-8404-4DF5-B0A4-3AE59F23A8FF Q27659686-5BE9AFBB-1BB5-4BCD-9570-E6CE64A16C61 Q28072448-3623208B-F1F2-45FA-BF3E-CD1B5B00BEC0 Q28216853-3C09B252-FE19-4B20-AB3D-202AE12903F3 Q28269958-2819771F-0872-4C21-A5B5-0DC7056A471F Q28505708-54849378-75E6-499D-AB53-CA0BC15CA12B Q28577668-217B4692-6A38-4D7D-BBD1-5378BFE8AB6D Q28585965-3155C8E7-385E-4100-A2B7-34B0B1D5CA79 Q28590754-9D79A3BC-73C2-4FD5-8586-4B4395701B86 Q28591834-DB38938B-CC44-4CB2-9327-86358CC1CAE9 Q28593523-4FA0D2E7-68FC-4070-9B44-01C766800E68 Q28741586-846FDFD6-DE28-487C-96BE-71F6C15F1263 Q28829519-C48D4E5D-AE97-4F47-9479-D066E45D0616 Q30479201-F9D527EA-4028-48A0-85E4-2FAA81116AE4 Q30514065-72679F43-EBDA-47BD-A779-28194F2618F7 Q30896811-230DD38B-8AED-4C2B-B621-82520BEAB5A8 Q33288480-4151146D-4E43-4BF1-8719-498BC9367644 Q33292411-32CFFD8F-3117-4755-9B9D-95D9D6B10644 Q33509896-5C38C8C4-7F46-4161-BC97-11B5ED3293C9 Q33556162-EC3C1821-F708-4309-BCFD-094CFE368EBD Q33627007-43859365-B0E4-4E13-85EC-3EC82D4FA0F8 Q33680436-B01716E1-1FC9-45ED-919D-DBA68D528BE2 Q33889468-BCABC0AA-4140-49B8-93B4-1D8DC8311ABC Q33920298-6EEBAF29-5D7B-4B11-AE63-F31491CB75BE Q33940058-B8EB9ECF-908B-49E2-BF2A-A0B3D091E8E2 Q34015299-94611662-1F06-4452-8F86-31FF46ED92D1 Q34026770-9A7BD1DB-8899-4CD0-B6A0-5DB3CBD0DC19 Q34066152-29863CD8-AC0E-46E3-979B-C0A1F108D473

P2860

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

http://www.wikidata.org/entity/Q24291630

description

2001 nî lūn-bûn

@nan

2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Isolated lymphatic endothelial ...... the VEGF-C/D receptor VEGFR-3

@ast

Isolated lymphatic endothelial ...... the VEGF-C/D receptor VEGFR-3

@en

Isolated lymphatic endothelial ...... the VEGF-C/D receptor VEGFR-3

@en-gb

Isolated lymphatic endothelial ...... the VEGF-C/D receptor VEGFR-3

@nl

type

label

Isolated lymphatic endothelial ...... the VEGF-C/D receptor VEGFR-3

@ast

Isolated lymphatic endothelial ...... the VEGF-C/D receptor VEGFR-3

@en

Isolated lymphatic endothelial ...... the VEGF-C/D receptor VEGFR-3

@en-gb

Isolated lymphatic endothelial ...... the VEGF-C/D receptor VEGFR-3

@nl

prefLabel

Isolated lymphatic endothelial ...... the VEGF-C/D receptor VEGFR-3

@ast

Isolated lymphatic endothelial ...... the VEGF-C/D receptor VEGFR-3

@en

Isolated lymphatic endothelial ...... the VEGF-C/D receptor VEGFR-3

@en-gb

Isolated lymphatic endothelial ...... the VEGF-C/D receptor VEGFR-3

@nl

P1433

Q24291630-EDE15308-ACCD-4F69-8541-F0224F626425

P1476

Q24291630-1C78B71D-A586-4744-9478-30C1F58C3F1B

P2093

Q24291630-10C548B1-4BBA-4522-A72B-ADBAEFA12998

Q24291630-3E46A537-10DF-4CCF-900F-F583ACA08C02

Q24291630-43EEA60F-E17C-4EF4-AEC4-834A63A1B9BA

Q24291630-69C3E9BD-5F5F-4D73-92B4-C5BC4D93DA9F

Q24291630-7BB1BA59-983F-497B-8909-2C1F07AD2A56

Q24291630-8066F72F-CB3A-4514-A22E-9185B487A72B

Q24291630-83F7735B-A8DD-462F-A6A8-BD5B0D716FCB

Q24291630-9753E1B9-DF20-4B49-ABD2-F89062A7097E

Q24291630-CEB26E1C-F3DC-482C-9D5D-4286515693D9

Q24291630-D247D04B-32B6-4C59-966A-AC61D72D676F

P2860

Q24291630-1349A7A7-3A01-4862-AB3D-785DC863AF85

Q24291630-17924E81-B05A-4952-9917-03238CDD266D

Q24291630-1D673975-1855-433F-9B0E-BBC7FAACC995

Q24291630-24825354-DDB0-46A1-912B-7355B8E3EE04

Q24291630-27B346F6-B085-4FC0-BA54-C45F4C988E01

Q24291630-2842F108-FE91-41CF-B232-2D9CABBAD47F

Q24291630-2B12AA87-BB60-4A76-A124-A9262C58813D

Q24291630-2DE8CCC2-0614-4BE1-B848-5273914512D4

Q24291630-32668A8F-E3C3-4BD8-B3B5-A71A5C2D53B1

Q24291630-38A9EDE6-F6CA-4875-A716-EA37C9CC6007

P304

Q24291630-74DC7B95-C688-4794-A8B9-20F6BD918773

P31

Q24291630-C9F8E7E4-E8CC-44EF-BF09-51CF370CC6BF

P3181

Q24291630-6ECED436-C1FE-45B3-99B2-134730C0F886

P356

Q24291630-2CA847A4-E023-4233-80E5-271B434941B6

P407

Q24291630-E77C5B41-A8C2-42AC-95A9-BD1504F358E8

P433

Q24291630-8AC26E3F-70DE-4380-83BE-D142A1591856

P478

Q24291630-668B56E4-0B5A-4B7E-9658-65DA185E602B

P50

Q24291630-91A20399-C915-4006-8EDC-F05871461C8F

Q24291630-B439B6B6-2474-4DE4-9E5F-C6A72CE64CB5

P577

Q24291630-71B5535C-9899-40A0-BFF1-3F6FE782E228

P5875

Q24291630-12E66BAC-4D90-4801-A52D-779063CB8A89

P698

Q24291630-314D5660-93B7-4432-AAD0-E38F5FECBB10

P921

Q24291630-2C4F32B0-2163-4661-8EB6-F6207A6B4D5B

Q24291630-ADC0CF23-926D-4A44-9F5D-8D273424E37A

P932

Q24291630-A41BA411-7D7A-42C8-A7F4-4F67F01A21C9

P3181

P356

P1433

The EMBO Journal

P1476

Isolated lymphatic endothelial ...... the VEGF-C/D receptor VEGFR-3

@en

P2093

B Catimel

http://www.w3.org/2001/XMLSchema#string

D Kerjaschki

http://www.w3.org/2001/XMLSchema#string

E C Nice

http://www.w3.org/2001/XMLSchema#string

H Kowalski

http://www.w3.org/2001/XMLSchema#string

L Wise

http://www.w3.org/2001/XMLSchema#string

M G Achen

http://www.w3.org/2001/XMLSchema#string

S A Stacker

http://www.w3.org/2001/XMLSchema#string

S Mustjoki

http://www.w3.org/2001/XMLSchema#string

T Karpanen

http://www.w3.org/2001/XMLSchema#string

T Mäkinen

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling

Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms

Phosphorylation and regulation of Raf by Akt (protein kinase B)

P304

4762-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2408291

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/EMBOJ/20.17.4762

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Andrew A. Mercer

P577

2001-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232792043

http://www.w3.org/2001/XMLSchema#string

P698

11532940

http://www.w3.org/2001/XMLSchema#string

P921

positive regulation of protein kinase C signaling

Fms related receptor tyrosine kinase 4

P932

125596

http://www.w3.org/2001/XMLSchema#string